$DNA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENENTECH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GENENTECH INC. Get notifications about new insider transactions in GENENTECH INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 20 2009 | DNA | GENENTECH INC | Yang Patrick Y | EVP, Product Operat ... | Option Exercise | D | 85.83 | 1,500 | 128,745 | 0 | |
Apr 20 2009 | DNA | GENENTECH INC | Yang Patrick Y | EVP, Product Operat ... | Option Exercise | D | 79.55 | 1,700 | 135,235 | 0 | |
Apr 20 2009 | DNA | GENENTECH INC | Yang Patrick Y | EVP, Product Operat ... | Option Exercise | D | 79.17 | 1,120 | 88,670 | 0 | |
Apr 20 2009 | DNA | GENENTECH INC | Yang Patrick Y | EVP, Product Operat ... | Option Exercise | D | 53.23 | 850 | 45,246 | 0 | |
Apr 20 2009 | DNA | GENENTECH INC | Yang Patrick Y | EVP, Product Operat ... | Option Exercise | D | 48.30 | 1,200 | 57,960 | 0 | |
Apr 20 2009 | DNA | GENENTECH INC | Yang Patrick Y | EVP, Product Operat ... | Option Exercise | D | 85.83 | 125,000 | 10,728,750 | 0 | |
Apr 20 2009 | DNA | GENENTECH INC | Yang Patrick Y | EVP, Product Operat ... | Option Exercise | D | 79.55 | 125,000 | 9,943,750 | 0 | |
Apr 20 2009 | DNA | GENENTECH INC | Yang Patrick Y | EVP, Product Operat ... | Option Exercise | D | 79.17 | 135,000 | 10,687,950 | 0 | |
Apr 20 2009 | DNA | GENENTECH INC | Yang Patrick Y | EVP, Product Operat ... | Option Exercise | D | 53.23 | 60,000 | 3,193,800 | 0 | |
Apr 20 2009 | DNA | GENENTECH INC | Yang Patrick Y | EVP, Product Operat ... | Option Exercise | D | 43.36 | 15,000 | 650,400 | 0 | |
Apr 20 2009 | DNA | GENENTECH INC | Yang Patrick Y | EVP, Product Operat ... | Sell | D | 95.00 | 1,866 | 177,270 | 0 | 1.9 K to 0 (-100.00 %) |
Apr 20 2009 | DNA | GENENTECH INC | Yang Patrick Y | EVP, Product Operat ... | Sell | D | 95.00 | 1,746 | 165,870 | 0 | 1.7 K to 0 (-100.00 %) |
Apr 20 2009 | DNA | GENENTECH INC | Yang Patrick Y | EVP, Product Operat ... | Gift | G | 0.00 | 294 | 0 | 1,746 | 2 K to 1.7 K (-14.41 %) |
Apr 20 2009 | DNA | GENENTECH INC | Yang Patrick Y | EVP, Product Operat ... | Gift | G | 0.00 | 274 | 0 | 2,040 | 2.3 K to 2 K (-11.84 %) |
Mar 31 2009 | DNA | GENENTECH INC | Andreatta Robert E | CONTROLLER & CAO | Option Exercise | D | 85.83 | 30,000 | 2,574,900 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | Andreatta Robert E | CONTROLLER & CAO | Option Exercise | D | 79.55 | 29,000 | 2,306,950 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | Andreatta Robert E | CONTROLLER & CAO | Option Exercise | D | 79.17 | 14,000 | 1,108,380 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | Andreatta Robert E | CONTROLLER & CAO | Option Exercise | D | 79.10 | 20,000 | 1,582,000 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | Andreatta Robert E | CONTROLLER & CAO | Option Exercise | D | 53.23 | 15,700 | 835,711 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | Andreatta Robert E | CONTROLLER & CAO | Option Exercise | D | 42.05 | 4,500 | 189,225 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | Andreatta Robert E | CONTROLLER & CAO | Option Exercise | D | 37.16 | 6,500 | 241,540 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | Andreatta Robert E | CONTROLLER & CAO | Sell | D | 95.00 | 1,263 | 119,985 | 0 | 1.3 K to 0 (-100.00 %) |
Mar 31 2009 | DNA | GENENTECH INC | Andreatta Robert E | CONTROLLER & CAO | Sell | D | 95.00 | 834 | 79,230 | 0 | 834 to 0 (-100.00 %) |
Mar 31 2009 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | D | 85.83 | 125,000 | 10,728,750 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | D | 79.55 | 125,000 | 9,943,750 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | D | 79.17 | 135,000 | 10,687,950 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | D | 53.23 | 5,938 | 316,080 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | D | 95.00 | 963 | 91,485 | 0 | 963 to 0 (-100.00 %) |
Mar 31 2009 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | D | 82.40 | 11,000 | 906,400 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | D | 80.40 | 15,000 | 1,206,000 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | D | 74.06 | 15,000 | 1,110,900 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | D | 58.63 | 20,000 | 1,172,600 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | D | 54.39 | 39,800 | 2,164,722 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | D | 32.84 | 8,000 | 262,720 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | D | 26.10 | 20,000 | 522,000 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | D | 21.47 | 40,000 | 858,800 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | D | 18.60 | 5,000 | 93,000 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Sell | D | 95.00 | 2,000 | 190,000 | 0 | 2 K to 0 (-100.00 %) |
Mar 30 2009 | DNA | GENENTECH INC | BOYER HERBERT W PH D | Director | Option Exercise | D | 82.40 | 11,000 | 906,400 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | BOYER HERBERT W PH D | Director | Option Exercise | D | 80.40 | 15,000 | 1,206,000 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | BOYER HERBERT W PH D | Director | Option Exercise | D | 74.06 | 15,000 | 1,110,900 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | BOYER HERBERT W PH D | Director | Option Exercise | D | 58.63 | 20,000 | 1,172,600 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | BOYER HERBERT W PH D | Director | Option Exercise | D | 54.39 | 39,800 | 2,164,722 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | BOYER HERBERT W PH D | Director | Sell | D | 95.00 | 27,500 | 2,612,500 | 0 | 27.5 K to 0 (-100.00 %) |
Mar 30 2009 | DNA | GENENTECH INC | REED DEBRA L | Director | Option Exercise | D | 89.78 | 30,000 | 2,693,400 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | REED DEBRA L | Director | Option Exercise | D | 82.40 | 11,000 | 906,400 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | REED DEBRA L | Director | Option Exercise | D | 80.40 | 15,000 | 1,206,000 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | REED DEBRA L | Director | Option Exercise | D | 74.06 | 15,000 | 1,110,900 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | D | 85.83 | 157,500 | 13,518,225 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | D | 79.55 | 125,000 | 9,943,750 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | D | 79.17 | 135,000 | 10,687,950 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | D | 53.23 | 150,000 | 7,984,500 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | D | 42.05 | 132,000 | 5,550,600 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | D | 20.90 | 106,400 | 2,223,760 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | D | 14.28 | 180,000 | 2,570,400 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | D | 95.00 | 4,977 | 472,815 | 0 | 5 K to 0 (-100.00 %) |
Mar 30 2009 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | D | 95.00 | 3,641 | 345,895 | 0 | 3.6 K to 0 (-100.00 %) |
Mar 30 2009 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | D | 85.83 | 705,000 | 60,510,150 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | D | 79.55 | 400,000 | 31,820,000 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | D | 79.17 | 500,000 | 39,585,000 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | D | 53.23 | 900,000 | 47,907,000 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | D | 42.05 | 640,000 | 26,912,000 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | D | 40.99 | 720,000 | 29,512,800 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | D | 20.90 | 720,000 | 15,048,000 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | D | 14.28 | 900,000 | 12,852,000 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | D | 12.13 | 689,304 | 8,361,258 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Sell | D | 95.00 | 9,566 | 908,770 | 0 | 9.6 K to 0 (-100.00 %) |
Mar 30 2009 | DNA | GENENTECH INC | SCHELLER RICHARD H | EVP-RESEARCH | Option Exercise | D | 85.83 | 165,000 | 14,161,950 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | SCHELLER RICHARD H | EVP-RESEARCH | Option Exercise | D | 79.55 | 125,000 | 9,943,750 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | SCHELLER RICHARD H | EVP-RESEARCH | Option Exercise | D | 79.17 | 135,000 | 10,687,950 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | SCHELLER RICHARD H | EVP-RESEARCH | Option Exercise | D | 53.23 | 12,500 | 665,375 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | JUELSGAARD STEPHEN G | EVP, CCO & SECRETAR ... | Option Exercise | D | 85.83 | 165,000 | 14,161,950 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | JUELSGAARD STEPHEN G | EVP, CCO & SECRETAR ... | Option Exercise | D | 79.55 | 125,000 | 9,943,750 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | JUELSGAARD STEPHEN G | EVP, CCO & SECRETAR ... | Option Exercise | D | 79.17 | 135,000 | 10,687,950 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | JUELSGAARD STEPHEN G | EVP, CCO & SECRETAR ... | Option Exercise | D | 53.23 | 200,000 | 10,646,000 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | JUELSGAARD STEPHEN G | EVP, CCO & SECRETAR ... | Option Exercise | D | 42.05 | 200,000 | 8,410,000 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | JUELSGAARD STEPHEN G | EVP, CCO & SECRETAR ... | Sell | D | 95.00 | 5,766 | 547,770 | 0 | 5.8 K to 0 (-100.00 %) |
Mar 30 2009 | DNA | GENENTECH INC | Tessier-Lavigne Marc | EVP, RESEARCH DRUG ... | Option Exercise | D | 85.83 | 75,000 | 6,437,250 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | Tessier-Lavigne Marc | EVP, RESEARCH DRUG ... | Option Exercise | D | 79.55 | 57,000 | 4,534,350 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | Tessier-Lavigne Marc | EVP, RESEARCH DRUG ... | Option Exercise | D | 79.17 | 72,000 | 5,700,240 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | Tessier-Lavigne Marc | EVP, RESEARCH DRUG ... | Option Exercise | D | 73.47 | 55,000 | 4,040,850 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | Tessier-Lavigne Marc | EVP, RESEARCH DRUG ... | Option Exercise | D | 53.23 | 5,625 | 299,419 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | Tessier-Lavigne Marc | EVP, RESEARCH DRUG ... | Sell | D | 95.00 | 1,159 | 110,105 | 0 | 1.2 K to 0 (-100.00 %) |
Mar 30 2009 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | PRESIDENT, | Option Exercise | D | 85.83 | 300,000 | 25,749,000 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | PRESIDENT, | Option Exercise | D | 79.55 | 210,000 | 16,705,500 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | PRESIDENT, | Option Exercise | D | 79.17 | 240,000 | 19,000,800 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | PRESIDENT, | Option Exercise | D | 53.23 | 360,000 | 19,162,800 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | PRESIDENT, | Option Exercise | D | 42.05 | 360,000 | 15,138,000 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | PRESIDENT, | Option Exercise | D | 40.99 | 362,808 | 14,871,500 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | PRESIDENT, | Option Exercise | D | 20.90 | 175,000 | 3,657,500 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | PRESIDENT, | Sell | D | 95.00 | 1,639 | 155,705 | 0 | 1.6 K to 0 (-100.00 %) |
Jan 20 2009 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Gift | G | 0.00 | 122 | 0 | 4,977 | 4.9 K to 5 K (+2.51 %) |
Jan 20 2009 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Gift | G | 0.00 | 122 | 0 | 3,533 | 3.7 K to 3.5 K (-3.34 %) |
Mar 30 2009 | DNA | GENENTECH INC | Barron Hal | SVP - DEVELOPMENT & ... | Option Exercise | D | 85.83 | 75,000 | 6,437,250 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | Barron Hal | SVP - DEVELOPMENT & ... | Option Exercise | D | 79.55 | 57,000 | 4,534,350 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | Barron Hal | SVP - DEVELOPMENT & ... | Option Exercise | D | 79.17 | 72,000 | 5,700,240 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | Barron Hal | SVP - DEVELOPMENT & ... | Option Exercise | D | 53.23 | 95,000 | 5,056,850 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | Barron Hal | SVP - DEVELOPMENT & ... | Option Exercise | D | 42.05 | 100,000 | 4,205,000 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | Barron Hal | SVP - DEVELOPMENT & ... | Option Exercise | D | 20.90 | 2,917 | 60,965 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | Barron Hal | SVP - DEVELOPMENT & ... | Option Exercise | D | 18.88 | 5,625 | 106,200 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | Barron Hal | SVP - DEVELOPMENT & ... | Option Exercise | D | 14.28 | 23,458 | 334,980 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | Barron Hal | SVP - DEVELOPMENT & ... | Sell | D | 95.00 | 1,740 | 165,300 | 0 | 1.7 K to 0 (-100.00 %) |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 5,362 | 65,041 | 689,304 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 2,100 | 25,473 | 694,666 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 993 | 12,045 | 696,766 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 500 | 6,065 | 697,759 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 1,500 | 18,195 | 698,259 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 900 | 10,917 | 699,759 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 294 | 3,566 | 700,659 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 3,200 | 38,816 | 700,953 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 600 | 7,278 | 704,153 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 2,800 | 33,964 | 704,753 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 1,100 | 13,343 | 707,553 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 700 | 8,491 | 708,653 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 2,400 | 29,112 | 709,353 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 900 | 10,917 | 711,753 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 3,900 | 47,307 | 712,653 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 150 | 1,820 | 716,553 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 800 | 9,704 | 716,703 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 800 | 9,704 | 717,503 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 302 | 3,663 | 718,303 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 1,300 | 15,769 | 718,605 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 600 | 7,278 | 719,905 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 1,300 | 15,769 | 720,505 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 600 | 7,278 | 721,805 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 600 | 7,278 | 722,405 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 600 | 7,278 | 723,005 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 200 | 2,426 | 723,605 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 500 | 6,065 | 723,805 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 700 | 8,491 | 724,305 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 300 | 3,639 | 725,005 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 1,700 | 20,621 | 725,305 | |
Jul 23 2008 | DNA | GENENTECH INC | Yang Patrick Y | EVP-PRODUCT OPERATI ... | Option Exercise | M | 43.36 | 50,000 | 2,168,000 | 15,000 | |
Jul 23 2008 | DNA | GENENTECH INC | Yang Patrick Y | EVP-PRODUCT OPERATI ... | Sell | S | 92.98 | 50,000 | 4,649,000 | 2,205 | 52.2 K to 2.2 K (-95.78 %) |
Jul 23 2008 | DNA | GENENTECH INC | Yang Patrick Y | EVP-PRODUCT OPERATI ... | Buy | M | 43.36 | 50,000 | 2,168,000 | 52,205 | 2.2 K to 52.2 K (+2,267.57 %) |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 100 | 1,213 | 727,005 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 13,954 | 169,262 | 727,105 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 800 | 9,704 | 741,059 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 1,000 | 12,130 | 741,859 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 1,200 | 14,556 | 742,859 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 1,200 | 14,556 | 744,059 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 2,246 | 27,244 | 745,259 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 400 | 4,852 | 747,505 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 1,800 | 21,834 | 747,905 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 1,400 | 16,982 | 749,705 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 100 | 1,213 | 751,105 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 1,870 | 22,683 | 751,205 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 400 | 4,852 | 753,075 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 1,700 | 20,621 | 753,475 | |
Jul 22 2008 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN & CEO | Option Exercise | M | 12.13 | 2,500 | 30,325 | 755,175 |